Production (Stage)
Knight Therapeutics Inc.
KHTRF
$4.17
-$0.289-6.48%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 161.52% | 123.95% | -305.02% | -34.85% | -16.72% |
| Total Depreciation and Amortization | 1.27% | 3.76% | -15.67% | -17.59% | -21.90% |
| Total Amortization of Deferred Charges | 2.25% | 2.25% | 35.60% | 35.60% | 35.60% |
| Total Other Non-Cash Items | -126.11% | -103.83% | 899.26% | 1,691.68% | 283.56% |
| Change in Net Operating Assets | -2,070.03% | 32.82% | 93.84% | 106.69% | 112.22% |
| Cash from Operations | -85.98% | 0.97% | 113.20% | 191.06% | 68.35% |
| Capital Expenditure | -11.87% | -163.38% | 12.72% | 27.27% | 41.51% |
| Sale of Property, Plant, and Equipment | -93.51% | -91.76% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 429.12% | -35.97% | 90.62% | 131.07% | 115.16% |
| Cash from Investing | 407.25% | -45.95% | 90.11% | 129.35% | 114.93% |
| Total Debt Issued | 0.92% | -27.59% | -94.78% | -92.52% | -90.97% |
| Total Debt Repaid | 9.68% | 5.68% | -8.44% | -23.72% | -13.25% |
| Issuance of Common Stock | 187.85% | 163.68% | 141.06% | 59.63% | 1.40% |
| Repurchase of Common Stock | 71.51% | 83.39% | 46.96% | 19.82% | -26.38% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 28.39% | 22.82% | -30.35% | -41.96% | -115.25% |
| Cash from Financing | 52.22% | 59.39% | -204.48% | -406.36% | -718.43% |
| Foreign Exchange rate Adjustments | -14.13% | -41.54% | -76.69% | -99.72% | -66.39% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 579.22% | 267.10% | 84.95% | 142.64% | 111.97% |